Structurally adaptive hot spots at a protein interaction interface on TRAF3

Journal of Molecular Recognition

Volumn 15, Issue 5, 2002, Pages 286-290

  Ely, Kathryn R ^a   Li, Chenglong ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Crystallography; Cytokine receptor; Hot spots; Molecular adaptation; Protein protein interactions; Signal transduction; Surface characterization; TANK; TRAF proteins; Tumor necrosis factor receptor

Indexed keywords

TUMOR NECROSIS FACTOR; AMINO ACID; PROTEIN; PROTEIN SUBUNIT; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3;

BINDING SITE; IMMUNE RESPONSE; PROTEIN INTERACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; ELECTRICITY; HUMAN; HYDROPHOBICITY; IN VITRO STUDY; METABOLISM; PROTEIN QUATERNARY STRUCTURE; REVIEW;

AMINO ACIDS; ANIMALS; BINDING SITES; ELECTROSTATICS; HUMANS; HYDROPHOBICITY; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEIN STRUCTURE, QUATERNARY; PROTEIN SUBUNITS; PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 3;

EID: 0036760956     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmr.589     Document Type: Review

References (40)

1. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S. 1994. The CD40 antigen and its ligand. A. Rev. Immunol. 12: 881-922.
2. Barnett P, Bottger G, Klein AT, Tabak HF, Distel B. 2000. The peroxisomal membrane protein Pex13p shows a novel mode of SH3 interaction. Embo J. 19: 6382-6391.
3. Bogan AA, Thorn KS. 1998. Anatomy of hot spots in protein interfaces. J. Mol. Biol. 280: 1-9.
4. Cheng G, Baltimore D. 1996. TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation. Genes Dev. 10: 963-973.
5. Cheng G, Cleary AM, Ye ZS, Hong DI, Lederman S, Baltimore D. 1995. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267: 1494-1498.
6. Chung JY, Park YC, Ye H, Wu H. 2002. All TRAFs are not created equal: Common and distinct molecular mechanisms of TRAF-mediated signal transduction. J. Cell Sci. 115: 679-688.
7. Clackson T, Wells JA. 1995. A hot spot of binding energy in a hormone-receptor interface. Science 267: 383-386.
8. Clark EA, Ledbetter JA. 1994. How B and T cells talk to each other. Nature 367: 425-428.
9. DeLano WL. 2002. Unraveling hot spots in binding interfaces: Progress and challenges. Curr. Opin. Struct. Biol. 12: 14-20.
10. DeLano WL, Ultsch MH, de Vos AM, Wells JA. 2000. Convergent solutions to binding at a protein-protein interface. Science 287: 1279-1283.
11. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. 1997. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388: 548-554.
12. Force WR, Cheung TC, Ware CF. 1997. Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-beta receptor. J. Biol. Chem. 272: 30835-30840.
13. Force WR, Glass AA, Benedict CA, Cheung TC, Lama J, Ware CF. 2000. Discrete signaling regions in the lymphotoxin-beta receptor for tumor necrosis factor receptor-associated factor binding, subcellular localization, and activation of cell death and NF-kappaB pathways. J. Biol. Chem. 275: 11121-11129.
14. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ. 1996. Immune regulation by CD40 and its ligand gp39. A. Rev. Immunol. 14: 591-617.
15. Grammer AC, Swantek JL, McFarland RD, Miura Y, Geppert T, Lipsky PE. 1998. TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells. J. Immunol. 161: 1183-1193.
16. Grech A, Quinn R, Srinivasan D, Badoux X, Brink R. 2000. Complete structural characterisation of the mammalian and Drosophila TRAF genes: Implications for TRAF evolution and the role of RING finger splice variants. Mol. Immunol. 37: 721-734.
17. Harris BZ, Hillier BJ, Lim WA. 2001. Energetic determinants of internal motif recognition by PDZ domains. Biochemistry 40: 5921-5930.
18. Hu Z, Ma B, Wolfson H, Nussinov R. 2000. Conservation of polar residues as hot spots at protein interfaces. Proteins 39: 331-342.
19. Jones S, Thornton JM. 1996. Principles of protein-protein interactions. Proc. Natl. Acad. Sci. USA 93: 13-20.
20. Jones TA, Zou J-Y, Cowan SW, Kjeldgaard M. 1991. Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr. 47: 110-119.
21. Koradi R, Billeter M, Wuthrich K. 1996. MOLMOL: A program for display and analysis of macromolecular structures. J. Mol. Graph. 14: 51-55.
22. Li C, Ni C-Z, Havert ML, Cabezas E, He J, Kaiser D, Reed JC, Satterthwait AC, Cheng G, Ely KR. 2002. Downstream regulator TANK binds to the CD40 recognition site on TRAF3. Structure 10: 403-411.
23. Liu ZG, Hsu H, Goeddel DV, Karin M. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87: 565-576.
24. Lo Conte L, Chothia C, Janin J. 1999. The atomic structure of protein-protein recognition sites. J. Mol. Biol. 285: 2177-2198.
25. Malinin NL, Boldin MP, Kovalenko AV, Wallach D. 1997. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 385: 540-544.
26. McWhirter SM, Pullen SS, Holton JM, Crute JJ, Kehry MR, Alber T. 1999. Crystallographic analysis of CD40 recognition and signaling by human TRAF2. Proc. Natl. Acad. Sci. USA 96: 8408-8413.
27. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, Rao A. 1997. IKK-1 and IKK-2: Cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278: 860-866.
28. Najmanovich R, Kuttner J, Sobolev V, Edelman M. 2000. Side-chain flexibility in proteins upon ligand binding. Proteins 39: 261-268.
29. Natoli G, Costanzo A, Ianni A, Templeton DJ, Woodgett JR, Balsano C, Levrero M. 1997. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 275: 200-203.
30. Ni C-Z, Welsh K, Leo E, Chiou CK, Wu H, Reed JC, Ely KR. 2000. Molecular basis for CD40 signaling mediated by TRAF3. Proc. Natl. Acad. Sci. USA 97: 10395-10399.
31. Nicholls A, Honig B. 1990. A rapid finite difference algorithm, utilizing successive over-relaxation to solve the Poisson-Bolzmann equation. J. Comput. Chem. 12: 435-445.
32. Park YC, Burkitt V, Villa AR, Tong L, Wu H. 1999. Structural basis for self-association and receptor recognition of human TRAF2. Nature 398: 533-538.
33. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M. 1997. Identification and characterization of an IkappaB kinase. Cell 90: 373-383.
34. Roseman MA. 1988. Hydrophobicity of polar amino acid side-chains is markedly reduced by flanking peptide bonds. J. Mol. Biol. 200: 513-522.
35. Rothe M, Xiong J, Shu HB, Williamson K, Goddard A, Goeddel DV. 1996. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. Proc. Natl. Acad. Sci. USA 93: 8241-8246.
36. Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, Mirtsos C, Takada H, Wakeham A, Itie A, Li S, Penninger JM, Wesche H, Ohashi PS, Mak TW, Yeh WC. 2002. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416: 750-756.
37. Thorn KS, Bogan AA. 2001. ASEdb: A database of alanine mutations and their effects on the free energy of binding in protein interactions. Bioinformatics 17: 284-285.
38. Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV. 1997. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 278: 866-869.
39. Ye H, Park YC, Kreishman M, Kieff E, Wu H. 1999. The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol. Cell 4: 321-330.
40. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. 1997. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91: 243-252.